Serum-Oxford Covid-19 vaccine gets DCGI nod for phase 2, 3 clinical trials in India

Currently, phase 2, 3 clinical trials of the Oxford sponsor vaccine is ongoing in United Kingdom.The vaccine was manufactured by Serum in India under technical collaboration with Oxford University/Astra Zeneca and is called as COVISHIELD

from Livemint - Science https://ift.tt/31eHhGq
https://ift.tt/eA8V8J